Atarax Filmuhúðuð tafla 25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

atarax filmuhúðuð tafla 25 mg

ucb nordic a/s - hydroxyzinum hýdróklóríð - filmuhúðuð tafla - 25 mg

Atarax Mixtúra, lausn 2 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

atarax mixtúra, lausn 2 mg/ml

ucb nordic a/s - hydroxyzinum hýdróklóríð - mixtúra, lausn - 2 mg/ml

Hydroxyzine Medical Valley Filmuhúðuð tafla 25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

hydroxyzine medical valley filmuhúðuð tafla 25 mg

medical valley invest ab - hydroxyzinum hýdróklóríð - filmuhúðuð tafla - 25 mg

Tibsovo Evrópusambandið - íslenska - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - Æxlishemjandi lyf - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.